CN104921775A - Postoperative tourniquet for percutaneous coronary intervention treatment - Google Patents

Postoperative tourniquet for percutaneous coronary intervention treatment Download PDF

Info

Publication number
CN104921775A
CN104921775A CN201510306902.2A CN201510306902A CN104921775A CN 104921775 A CN104921775 A CN 104921775A CN 201510306902 A CN201510306902 A CN 201510306902A CN 104921775 A CN104921775 A CN 104921775A
Authority
CN
China
Prior art keywords
tourniquet
fixing plate
plate
percutaneous coronary
main
Prior art date
Application number
CN201510306902.2A
Other languages
Chinese (zh)
Other versions
CN104921775B (en
Inventor
钱陈
高坚杰
曹艳
Original Assignee
常州药物研究所有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 常州药物研究所有限公司 filed Critical 常州药物研究所有限公司
Priority to CN201510306902.2A priority Critical patent/CN104921775B/en
Publication of CN104921775A publication Critical patent/CN104921775A/en
Application granted granted Critical
Publication of CN104921775B publication Critical patent/CN104921775B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12009Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/132Tourniquets
    • A61B17/1322Tourniquets comprising a flexible encircling member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/132Tourniquets
    • A61B17/1322Tourniquets comprising a flexible encircling member
    • A61B17/1325Tourniquets comprising a flexible encircling member with means for applying local pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00Devices for applying, e.g. spreading, media, e.g. remedies, on the human body
    • A61M35/003Portable hand-held applicators having means for dispensing or spreading integral media
    • A61M35/006Portable hand-held applicators having means for dispensing or spreading integral media using sponges, foams, absorbent pads or swabs as spreading means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B2017/12004Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12009Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
    • A61B2017/12018Elastic band ligators

Abstract

The invention relates to a postoperative tourniquet for percutaneous coronary intervention treatment. The postoperative tourniquet for percutaneous coronary intervention treatment comprises a main fixing plate, wherein a hemostasis module is arranged on the main fixing plate, and fixing adhesive tapes are respectively connected to two sides of the main fixing plate. The hemostasis module comprises a supporting plate and a hemostasis material layer, wherein the supporting plate is arranged on the main fixing plate, the hemostasis material layer is arranged on the supporting plate and comprises two PVA layers and a collagen layer arranged between the PVA layers. The postoperative tourniquet for percutaneous coronary intervention treatment can achieve quick hemostasis, the working amount of mecical workers can be reduced, and a simple hemostasis device can be replaced. The postoperative tourniquet is convenient to use, a hemostasis material is made of an expansible material, can intelligently exert pressure without pressure regulation, misoperation is avoided, and errhysis is decreased to the most degree.

Description

经皮冠状动脉介入治疗术后用止血带 Percutaneous coronary intervention after surgery with a tourniquet

技术领域 FIELD

[0001] 本发明涉及一种经皮冠状动脉介入治疗术后用止血带。 [0001] The present invention relates to a percutaneous coronary intervention after tourniquet.

背景技术 Background technique

[0002] 当前,随着我国经济的快速发展,人们生活水平稳步提高,我国冠心病的发病率也逐渐增多。 [0002] Nowadays, with the rapid development of China's economy, people's living standards improved steadily, the incidence of coronary heart disease is gradually increasing. 治疗重度冠心病的最佳手段是介入疗法,其基本原理是将球囊导管通过血管穿刺置入狭窄的血管内,在体外将球囊加压膨胀,撑开狭窄的血管壁,使病变血管恢复畅通。 Means the best treatment of severe coronary artery disease interventional therapy, the basic principle is to puncture a blood vessel by a balloon catheter into the vascular stenosis, the balloon is pressurized in vitro expansion, open stenosed vessel wall, vascular lesions Recovery smooth. 包括:①经皮冠状动脉腔内成形术冠状动脉斑块旋切术冠状动脉斑块旋磨术;④冠状动脉斑块切吸术;⑤经皮冠状动脉激光成形术;©冠状动脉内支架等。 They include: ① percutaneous transluminal coronary angioplasty coronary atherectomy coronary atherectomy plaque technique; ④ coronary plaque discectomy; ⑤ laser percutaneous transluminal coronary angioplasty; Coronary stents within © . 目前,应用广泛的介入治疗术是经皮冠状动脉腔内成形术及冠脉支架术。 Currently, the widely used interventional therapy is percutaneous transluminal coronary angioplasty (PTCA) and Stenting.

[0003] 经皮股动脉穿刺是冠心病患者行冠状动脉介入诊疗的经典途径,但存在患者术后卧床时间长、体位受限多,腹股沟血肿、动静脉瘘、皮肤溃破、血栓等并发症发生率高达(2%〜8% ),而且随着年龄的增大,成功率及安全性也逐渐降低等不足。 [0003] percutaneous femoral artery puncture is a classic way patients with coronary interventional diagnosis and treatment of coronary heart disease, but there is a long time bedridden patients after surgery, and more restricted position, the groin hematoma, arteriovenous fistula, skin ulceration, thrombosis and other complications high incidence (2% ~ 8%), and increases with age, the success rate is gradually reduced and safety and other issues. 近年来随着心导管器械的小型化,经桡动脉行冠脉介入诊疗已逐渐成为一种有益的替代。 In recent years, with miniaturization of cardiac catheterization equipment, transradial coronary interventional diagnosis and treatment it has become a useful alternative.

[0004] 在经过经皮冠脉介入术(PCI)后,穿刺点止血一般采用人工按压后,再用绷带加压处理,可能按压时间长达10小时以上,由于较长时间的指压会造成手部疲劳或感觉衰退,从而使医务人员对穿刺处施加压力减轻或者不均,因此易造成出血,渗血或血肿,给患者带来不必要的痛苦或其他严重后果,同时医务人员的劳动强度大,人工成本高,因此,用于压迫止血的器械不断问世。 [0004] After the intervention (PCI) after percutaneous coronary, generally stop the bleeding puncture site after artificial pressed, then bandage process, the pressing time may be up to 10 hours due to the finger pressure will cause a longer time hand fatigue or feeling the recession, so that the medical personnel put pressure on the puncture site or mitigate uneven, so easily lead to bleeding, bleeding or hematoma, cause unnecessary suffering to the patient or other serious consequences, while the labor intensity of medical personnel large, high labor costs, therefore, for hemostasis devices continue to come out.

[0005] 现有技术一般通过给球囊加压或者通过螺丝提供压力,在使用过程中需要不断调节压力,医护人员工作强度加大。 [0005] Usually the prior art by providing a pressure to the balloon by a screw or pressure, in the course of the need to constantly adjust the pressure, increase staff workloads. 整套止血设备基本为一次性使用,导致材料的浪费。 The basic package of hemostatic devices for single use, resulting in a waste of materials. 止血材料主要通过加压方式进行,而无法起到凝血作用的,导致凝血时间较长,给患者带来不必要的伤害。 Hemostatic material mainly by way of pressure, but can not play a role in blood clotting, resulting in longer clotting time, cause unnecessary harm to patients.

发明内容 SUMMARY

[0006] 本发明要解决的技术问题是:克服现有技术的不足,提供一种登皮冠状动脉介入治疗术后用止血带。 [0006] The present invention to solve the technical problem: to overcome the deficiencies of the prior art, to provide a Dengpi after percutaneous coronary intervention with a tourniquet.

[0007] 本发明解决其技术问题所采用的技术方案是:一种经皮冠状动脉介入治疗术后用止血带,包括主固定板,所述主固定板上设置止血模块,所述主固定板两侧分别连接有固定胶带; [0007] aspect of the present invention to solve the technical problem is: A percutaneous coronary intervention after tourniquet, comprising a main fixing plate, said fixing plate disposed hemostatic main module, the main fixing plate are connected on both sides adhesive tape;

[0008] 所述的止血模块包括托板和止血材料层,所述托板设置在主固定板上,所述的止血材料层设置在托板上,所述的止血材料层包括两PVA层以及设置在两PVA层之间的胶原蛋白层。 [0008] The hemostatic module comprises a hemostatic material layer and a pallet, the pallet is provided on the main fixing plate, said hemostatic material layer disposed on the pallet, the hemostatic material layer comprises two layers and PVA the collagen layer disposed between the two PVA layer.

[0009] 进一步的,所述主固定板的两侧分别连接有副固定板,所述副固定板的两端分别设置有铰链,所述副固定板的一端经铰链与主固定板形成转动连接,所述副固定板的另一端经铰链与固定胶带形成转动连接。 [0009] Further, both sides of the main fixing plate fixed to the sub plate respectively connected with the two ends of the sub-fixing plate are provided with a hinge, one end of the sub-fixing plate is formed rotatably connected via a hinge fixed to the main plate the other end via a hinge fixing plate fixing tape sub-rotatable connection is formed.

[0010] 进一步的,所述的副固定板弯曲成弧状。 [0010] Further, the secondary fixing plate curved in an arc.

[0011] 进一步的,所述的托板与主固定板之间相卡接连接。 [0011] Further, between the stationary plate relative to the main pallet clamped connection.

[0012] 进一步的,所述的固定胶带为弹力带或者刺毛皮。 [0012] Further, the fixing elastic band or tape is barbed fur.

[0013] 本发明的有益效果是:本发明的止血带能够较快时间止血,减轻医护人员工作量的可更换简易止血设备。 [0013] Advantageous effects of the present invention are: the present invention can quickly tourniquet hemostasis time, reduce the workload of medical device may be replaceable simple hemostasis. 使用方便,止血材料采用膨胀性材料,可智能施压,无需进行压力调节,避免了操作失误的发生,最大限度得减少渗血。 Easy to use, use of expandable hemostatic material material, intelligent pressure, without pressure adjustment, to avoid the occurrence of operational errors, get the maximum decrease bleeding.

[0014] 胶原蛋白止血材料可以快速凝血。 [0014] collagen hemostatic material quick coagulation.

[0015] 止血材料的模块化处理,可以减少材料的浪费,并使其更新换代更加简便。 Modular processing [0015] hemostatic material can reduce material waste and make it easier replacement.

附图说明 BRIEF DESCRIPTION

[0016] 下面结合附图对本发明进一步说明。 [0016] DRAWINGS The present invention is further described.

[0017] 图1是本发明止血带的示意图; [0017] FIG. 1 is a schematic view of the tourniquet of the present invention;

[0018] 图2是止血材料层的示意图; [0018] FIG. 2 is a schematic view of a hemostatic material layer;

[0019] 图3是止血带的侧面视图; [0019] FIG. 3 is a side view of a tourniquet;

[0020] 其中,21、固定胶带,22、铰链,23、主固定板,24、副固定板,27、托板,28、止血材料层,11、PVA层,12、胶原蛋白层。 [0020] wherein, 21, the adhesive tape 22, the hinge 23, fixed to the main plate 24, fixed to the sub plate 27, the pallet 28, a hemostatic material layer, 11, PVA layer 12, the collagen layer.

具体实施方式 Detailed ways

[0021] 现在结合具体实施例对本发明作进一步的说明。 [0021] Now with reference to specific embodiments of the present invention will be further described. 这些附图均为简化的示意图仅以示意方式说明本发明的基本结构,因此其仅显示与本发明有关的构成。 These figures are merely schematic manner a simplified schematic explaining the basic structure of the invention, therefore only the configuration of the display related to the present invention.

[0022] 如图1至图3所示,一种经皮冠状动脉介入治疗术后用止血带,包括主固定板23,主固定板23上设置止血模块,主固定板23两侧分别连接有固定胶带21。 [0022] As shown in FIG. 1 to FIG. 3 A percutaneous coronary intervention after tourniquet, includes a main mounting plate 23 is provided on the primary hemostatic module mounting plate 23, the fixed sides of the main plate 23 are connected fixing tape 21.

[0023] 止血模块包括托板27和止血材料层28,托板27设置在主固定板23上,止血材料层28设置在托板27上,止血材料层28包括两PVA层11以及设置在两PVA层11之间的胶原蛋白层12。 [0023] module comprises a pallet 27 and a hemostatic hemostatic material layer 28, the pallet 27 is provided on the main fixing plate 23, a hemostatic material layer 28 is disposed on the pallet 27, the hemostatic material comprises two layers 28 and the PVA layer 11 provided on both the collagen layer 12 between the layer 11 PVA.

[0024] PVA层11采用为吸水膨胀型PVA,并且PVA层11可更替为含银(离子态或者结晶态)PVA材料,增强其抗菌性能。 [0024] PVA layer 11 is adopted as the water swelling type PVA, and PVA layer 11 may alternate as silver (ions or crystalline state) PVA material, to enhance its antibacterial properties.

[0025] 胶原蛋白层12采用胶原蛋白混合透明质酸钠等其他生物材料,用于增加膨胀度;胶原蛋白层12中增加凝血酶等生物质可以缩短凝血时间;胶原蛋白层12中增加壳聚糖等材料复合,可以增加止血和抗菌性能。 [0025] Collagen layer 12 using other biological material such as sodium hyaluronate mixed collagen, for increasing the degree of expansion; collagen layer 12 to increase the biomass thrombin clotting time can be shortened; collagen layer 12 increases chitosan sugar and other composite materials, can increase hemostasis and antibacterial properties.

[0026] 主固定板23的两侧分别连接有副固定板24,副固定板24的两端分别设置有铰链22,副固定板24的一端经铰链22与主固定板23形成转动连接,副固定板24的另一端经铰链22与固定胶带21形成转动连接。 [0026] The sides of the main mounting plate 23 are respectively connected to the sub-fixing plate 24, across the secondary fixing plate 24 are respectively provided with a hinge 22, one end of the auxiliary stationary plate 24 is rotatably connected via a hinge 22 is formed with the main mounting plate 23, sub the other end of the fixing plate 24 via a hinge 22 rotatably connected to the fixing tape 21 is formed.

[0027] 副固定板24弯曲成弧状。 [0027] Vice fixing plate 24 curved in an arc. 从而可以更好的适应手腕。 Which can better adapt to the wrist.

[0028] 托板27与主固定板23之间相卡接连接。 [0028] with a snap connection between the pallet 27 and the main plate 23 is fixed. 利用托板27与主固定板23之间的卡接连接,可以实现止血材料的模块化处理,可以减少材料的浪费,并使其更新换代更加简便。 Using the engagement between the pallet 27 and the main stationary contact plate 23 is connected, may be implemented modular processing hemostatic material, the waste material can be reduced, and make replacement easier.

[0029] 固定胶带21为弹力带或者刺毛皮。 [0029] The fixing elastic band or tape 21 is barbed fur. 从而使固定胶带21使用起来更加方便。 So that the adhesive tape 21 easier to use.

[0030] 在PCI手术结束后,用止血带将止血材料层28贴合与伤口处,并抽紧固定,在少量渗血发生时,止血材料层28即发生膨胀,智能施压从而最大限度降低渗血。 [0030] PCI after surgery, tourniquet hemostatic material layer 28 is bonded to the wound and secured tightening, when the small amount of bleeding occurs, i.e. hemostatic material layer 28 expands, thereby minimizing pressure intelligence oozing. 同时胶原蛋白能够起到快速止血的作用,PVA层11在此过程中能够智能膨胀,同时起到物理隔断作用。 Collagen can play while rapid hemostasis, PVA layer 11 in this process can be a smart expansion, also play the role of physical partition.

[0031] 以上述依据本发明的理想实施例为启示,通过上述的说明内容,相关工作人员完全可以在不偏离本项发明技术思想的范围内,进行多样的变更以及修改。 [0031] In the above-described embodiments of the present invention is based on the vision revelation, the above described content, relevant staff can without departing from the scope of the technical ideas of the present inventions, a variety of changes and modifications. 本项发明的技术性范围并不局限于说明书上的内容,必须要根据权利要求范围来确定其技术性范围。 Technical scope of the present invention is not limited to the content item on the instructions must be used to determine the technical scope according to the claims.

Claims (5)

1.一种经皮冠状动脉介入治疗术后用止血带,其特征是,包括主固定板(23),所述主固定板(23)上设置止血模块,所述主固定板(23)两侧分别连接有固定胶带(21); 所述的止血模块包括托板(27)和止血材料层(28),所述托板(27)设置在主固定板(23)上,所述的止血材料层(28)设置在托板(27)上,所述的止血材料层(28)包括两PVA层(11)以及设置在两PVA层(11)之间的胶原蛋白层(12)。 A percutaneous coronary intervention after tourniquet, characterized in that, comprising a main fixing plate (23), the main fixing plate (23) provided on the module to stop bleeding, the main fixing plate (23) two are connected side adhesive tape (21); said hemostatic module comprises a pallet (27) and the haemostatic material layer (28), the pallet (27) provided on the main fixing plate (23), said hemostatic the material layer (28) disposed on the pallet (27), said hemostatic material layer (28) comprises two layers of collagen PVA layer (11) disposed between two PVA layer (11) (12).
2.根据权利要求1所述的经皮冠状动脉介入治疗术后用止血带,其特征是,所述主固定板(23)的两侧分别连接有副固定板(24),所述副固定板(24)的两端分别设置有铰链(22),所述副固定板(24)的一端经铰链(22)与主固定板(23)形成转动连接,所述副固定板(24)的另一端经铰链(22)与固定胶带(21)形成转动连接。 The percutaneous coronary according to claim 1 with a tourniquet after interventional treatment, characterized in that, on both sides of the main fixing plate (23) are respectively connected to the sub-fixing plate (24), the secondary fixing end plates (24) are respectively provided with a hinge (22), fixed to one end of the sub-plate (24) is formed rotatably connected via a hinge (22) fixed to the main plate (23), the secondary fixing plate (24) the other end of the adhesive tape (21) rotatably connected via a hinge (22).
3.根据权利要求2所述的经皮冠状动脉介入治疗术后用止血带,其特征是,所述的副固定板(24)弯曲成弧状。 3. percutaneous coronary according to claim 2 interventional therapy with a tourniquet, characterized in that the secondary fixing plate (24) curved in an arc.
4.根据权利要求1所述的经皮冠状动脉介入治疗术后用止血带,其特征是,所述的托板(27)与主固定板(23)之间相卡接连接。 The percutaneous coronary according to claim 1 with a tourniquet after interventional treatment, characterized in that, between said plate (27) fixed to the main plate (23) with snap connection.
5.根据权利要求1所述的经皮冠状动脉介入治疗术后用止血带,其特征是,所述的固定胶带(21)为弹力带或者刺毛皮。 The percutaneous coronary according to claim 1 with a tourniquet after interventional treatment, characterized in that said adhesive tape (21) of the elastic band or barbed fur.
CN201510306902.2A 2015-06-05 2015-06-05 Percutaneous coronary intervention after surgery with a tourniquet CN104921775B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510306902.2A CN104921775B (en) 2015-06-05 2015-06-05 Percutaneous coronary intervention after surgery with a tourniquet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510306902.2A CN104921775B (en) 2015-06-05 2015-06-05 Percutaneous coronary intervention after surgery with a tourniquet

Publications (2)

Publication Number Publication Date
CN104921775A true CN104921775A (en) 2015-09-23
CN104921775B CN104921775B (en) 2017-11-21

Family

ID=54109453

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510306902.2A CN104921775B (en) 2015-06-05 2015-06-05 Percutaneous coronary intervention after surgery with a tourniquet

Country Status (1)

Country Link
CN (1) CN104921775B (en)

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954109A (en) * 1974-08-02 1976-05-04 The Kendall Company Bandage to prevent local hematoma
DE3907522C1 (en) * 1989-03-08 1990-04-05 Matthias Dr. 8000 Muenchen De Weiler Compression bandage cushioning
US5507721A (en) * 1994-03-18 1996-04-16 Shippert; Ronald D. Medical apparatus and method for applying pressure and absorbing fluid
US5873890A (en) * 1995-07-26 1999-02-23 Porat; Michael System for prevention of blood spurts from blood vessels during removal of needle
CN2562735Y (en) * 2002-08-22 2003-07-30 杨观清 Disposable pressor hemostatic wound protective belt
US20050165445A1 (en) * 2003-02-04 2005-07-28 Damage Control Surgical Technologies, Inc. Method and apparatus for hemostasis
CN201175359Y (en) * 2008-02-18 2009-01-07 叶永强 Artery compression hemostasis device
CN201286796Y (en) * 2008-08-01 2009-08-12 杭州协合医疗用品有限公司 Anti-blocking hemostasia film with multi-layer composite structure
CN201831922U (en) * 2010-11-03 2011-05-18 深圳市保安医疗用品有限公司 Venous tourniquet
CN201959088U (en) * 2011-02-24 2011-09-07 北京利明达医药科技有限公司 Chitosan first aid hemostasis device
CN203263477U (en) * 2013-04-11 2013-11-06 广东省医疗器械研究所 Disposable radial artery hemostat
CN204723126U (en) * 2015-06-05 2015-10-28 常州药物研究所有限公司 Use tourniquet after percutaneous coronary intervention iatrotechnics

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954109A (en) * 1974-08-02 1976-05-04 The Kendall Company Bandage to prevent local hematoma
DE3907522C1 (en) * 1989-03-08 1990-04-05 Matthias Dr. 8000 Muenchen De Weiler Compression bandage cushioning
US5507721A (en) * 1994-03-18 1996-04-16 Shippert; Ronald D. Medical apparatus and method for applying pressure and absorbing fluid
US5873890A (en) * 1995-07-26 1999-02-23 Porat; Michael System for prevention of blood spurts from blood vessels during removal of needle
CN2562735Y (en) * 2002-08-22 2003-07-30 杨观清 Disposable pressor hemostatic wound protective belt
US20050165445A1 (en) * 2003-02-04 2005-07-28 Damage Control Surgical Technologies, Inc. Method and apparatus for hemostasis
CN201175359Y (en) * 2008-02-18 2009-01-07 叶永强 Artery compression hemostasis device
CN201286796Y (en) * 2008-08-01 2009-08-12 杭州协合医疗用品有限公司 Anti-blocking hemostasia film with multi-layer composite structure
CN201831922U (en) * 2010-11-03 2011-05-18 深圳市保安医疗用品有限公司 Venous tourniquet
CN201959088U (en) * 2011-02-24 2011-09-07 北京利明达医药科技有限公司 Chitosan first aid hemostasis device
CN203263477U (en) * 2013-04-11 2013-11-06 广东省医疗器械研究所 Disposable radial artery hemostat
CN204723126U (en) * 2015-06-05 2015-10-28 常州药物研究所有限公司 Use tourniquet after percutaneous coronary intervention iatrotechnics

Also Published As

Publication number Publication date
CN104921775B (en) 2017-11-21

Similar Documents

Publication Publication Date Title
Zamboni et al. Minimally invasive surgical management of primary venous ulcers vs. compression treatment: a randomized clinical trial
Etufugh et al. Venous ulcers
Callam et al. Lothian and Forth Valley Leg Ulcer Healing Trial, part 1: elastic versus non-elastic bandaging in the treatment of chronic leg ulceration
Eaglstein Occlusive dressings
Beldon Basic science of wound healing
White Evidence for atraumatic soft silicone wound dressing use
JP2005511237A (en) Apparatus and method applying coagulant treatment with external pressure to the puncture wound
Rogers et al. Predictors of postoperative complications of Ilizarov external ring fixators in the foot and ankle
Vowden et al. Wound dressings: principles and practice
Alvarez et al. Incorporating wound healing strategies to improve palliation (symptom management) in patients with chronic wounds
Alavi et al. What's new: Management of venous leg ulcers: Treating venous leg ulcers
WO2009091549A8 (en) Modified starch material of biocompatible hemostasis
King Impaired wound healing in patients with diabetes
Belcaro et al. Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol
White et al. Interventions to avoid maceration of the skin and wound bed
Romanelli et al. OASIS® wound matrix versus Hyaloskin® in the treatment of difficult‐to‐heal wounds of mixed arterial/venous aetiology
Kelechi et al. Chronic venous disease and venous leg ulcers: an evidence-based update
Saziye et al. Comparison of vacuum‐assisted closure device and conservative treatment for fasciotomy wound healing in ischaemia‐reperfusion syndrome: preliminary results
CN200977177Y (en) Blood vessel compression styptic closure device
Rudolph Pathophysiology and management of venous ulcers
Rudolph Standards of care for venous leg ulcers: compression therapy and moist wound healing
Maklebust Using wound care products to promote a healing environment
Strahovnik et al. Comparison of drainage techniques on prolonged serous drainage after total hip arthroplasty
Cavadas et al. Temporary catheter perfusion and artery-last sequence of repair in macroreplantations
CN102379733B (en) Hemostasis bandage

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
GR01